10-Q: Ultralife Reports Q3 Loss Amid Acquisition Costs, Margin Squeeze

Ultralife Corporation reported a net loss for Q3 2025, driven by increased operating expenses, higher interest costs from its Electrochem acquisition, and declining gross margins, despite overall revenue growth.

Summary

• Consolidated revenues for the three-month period ended September 30, 2025, increased by 21.5% to $43.371 million, compared to $35.694 million in the prior year.
• The revenue growth was primarily due to the inclusion of Electrochem sales of $6.797 million, with government/defense sales increasing 16.4% and commercial sales decreasing 5.7% (excluding Electrochem).
• Gross profit for the quarter was $9.619 million, up from $8.682 million, but gross margin declined by 210 basis points to 22.2% from 24.3% in the prior year.
• Operating expenses rose by 29.4% to $10.570 million, including $1.333 million for Electrochem and $1.085 million in one-time costs for the Calgary facility closure.
• The company reported an operating loss of $0.951 million for the quarter, a significant shift from an operating income of $0.511 million in the same period last year.
• Net loss attributable to Ultralife Corporation was $1.220 million, or ($0.07) per share, compared to net income of $0.258 million, or $0.02 per share, in Q3 2024.
• Adjusted EBITDA for Q3 2025 increased to $2.048 million (4.7% of revenues) from $1.919 million (5.4% of revenues) in Q3 2024.
• For the nine-month period, revenues increased 18.3% to $142.678 million, but net income attributable to Ultralife Corporation decreased 75.1% to $1.524 million, or $0.09 per share.
• A material weakness in internal control over financial reporting, related to accounting personnel, was identified and is undergoing remediation, though not yet fully remediated as of September 30, 2025.

Sentiment

Score: 4

Explanation: The company experienced a net loss for the quarter and a significant decline in net income for the nine-month period, coupled with reduced gross margins and increased operating expenses. While revenue growth was present, it was largely acquisition-driven, and organic commercial sales declined. Operational inefficiencies and a material weakness in internal controls are ongoing concerns. Remediation efforts and strategic initiatives are positive, but current financial performance is weak.

Positives

• Consolidated revenues increased by 21.5% for the three-month period and 18.3% for the nine-month period, reaching $43.371 million and $142.678 million respectively.
• The acquisition of Electrochem Solutions, Inc. contributed $6.797 million in revenue for the three-month period and $23.718 million for the nine-month period.
• Battery & Energy Products segment showed organic growth of 4.0% for the nine-month period, driven by a 44.3% increase in government/defense sales (excluding Electrochem).
• Adjusted EBITDA for the three-month period increased by 6.7% to $2.048 million.
• Cash balance increased to $9.260 million as of September 30, 2025, from $6.854 million at December 31, 2024, largely reflecting cash generated from operations.
• The company was in full compliance with its debt covenants under the New Credit Agreement as of September 30, 2025.
• Management has significantly strengthened its finance and accounting team as part of remediation efforts for internal control weaknesses, including new oversight roles and additional experienced personnel.

Negatives

• Gross margin declined by 210 basis points to 22.2% for the three-month period and by 250 basis points to 23.8% for the nine-month period, primarily due to unfavorable sales product mix, quality issues on incoming components, and lower factory throughput.
• Operating income shifted to a loss of $0.951 million for the three-month period, compared to an income of $0.511 million in the prior year.
• Net income attributable to Ultralife Corporation turned into a loss of $1.220 million for the three-month period and decreased by 75.1% to $1.524 million for the nine-month period.
• Diluted EPS decreased to ($0.07) for the three-month period and $0.09 for the nine-month period, down from $0.02 and $0.37 respectively.
• Interest and financing expense increased significantly by $819,000 for the three-month period and $1.905 million for the nine-month period due to financing the Electrochem acquisition.
• Commercial sales in the Battery & Energy Products segment (excluding Electrochem) decreased by 5.7% for the three-month period and 12.1% for the nine-month period, with notable declines in medical (-10.4% / -22.6%) and oil & gas (-13.3% / -15.5%) sales.
• Communications Systems revenues decreased by 35.7% for the nine-month period, attributed to timing of purchase orders and prior year shipments to a major international defense contractor.
• Operating expenses increased due to Electrochem's inclusion and one-time costs, including $1.085 million for the Calgary facility closure and litigation expenses for a cyber insurance claim.

Risks

• Changes in economic conditions, including inflation, tariffs, interest rates, and supply chain disruptions, could adversely affect business, revenues, and earnings.
• Reliance on certain key customers for a significant portion of revenues poses a concentration risk.
• Reductions or delays in U.S. and foreign military spending could impact government/defense sales.
• Challenges in developing new products or new commercial applications for products could hinder growth.
• Potential disruptions in the supply of raw materials and components or material increases in their costs due to various factors.
• The company's resources could be overwhelmed by growth, impacting operational efficiency.
• Breaches in information systems security and other disruptions in information technology systems pose operational and financial risks.
• Difficulty in recruiting and retaining top management and key personnel could affect leadership and operational stability.
• Unique risks associated with China operations, including geopolitical and regulatory factors.
• Fluctuations in the price of oil and the resulting impact on demand for downhole drilling products.
• Possible future declines in demand for products that use the company's batteries or communications systems.
• Safety risks, including the risk of fire, inherent in the manufacture, use, and transportation of Lithium batteries.
• Variability in quarterly and annual results and the price of common stock due to various internal and external factors.
• Rising interest rates could increase the cost of variable borrowings, impacting profitability.
• Customers purchasing product quantities that do not meet volume expectations in supply agreements.
• Impact of pandemics, causing delays in manufacturing and delivery of products.
• Potential costs attributable to product warranties and services.
• Inability to comply with changes to regulations for the shipment of products.
• Exposure to additional financial risks when entering new end-markets.
• Negative publicity concerning Lithium-ion batteries could harm brand reputation and sales.
• Exposure to foreign currency fluctuations impacting financial results.
• Ability to utilize net operating loss carryforwards may be limited.
• Inability to protect proprietary and intellectual property could lead to competitive disadvantages.
• Compliance with rules and procedures regarding contracting with the U.S. and foreign governments.
• Possible impairments of goodwill and other intangible assets due to changes in market conditions or business performance.
• Compliance with government regulations, including those related to conflict minerals.
• Exposure to possible violations of anti-corruption laws such as the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act.
• Known and unknown environmental matters could lead to liabilities and operational disruptions.
• Possible audits of contracts by the U.S. and foreign governments and their respective defense agencies.

Future Outlook

Management is intensifying efforts to address manufacturing inefficiencies, improve supply chain resiliency, and rationalize manufacturing operations to optimize operating leverage. Key priorities include converting new product development into revenue, advancing vertical integration in the oil & gas segment, and focusing on operational efficiency initiatives to achieve sustainable profitable growth and maximize brand value. The company expects positive operating cash flow and available borrowings to meet funding requirements for the foreseeable future.

Management Comments

• "We are intensifying our efforts to tackle the manufacturing inefficiencies as well as improve supply chain resiliency and rationalize our manufacturing operations."
• "These actions are critical to ensuring we are best prepared to optimize the operating leverage of our business model as we advance several new products into qualification and production, and capitalize on an expanding pipeline of opportunities consisting primarily of large, multi-year programs."
• "Our priorities remain converting long-term new product development efforts into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth and maximizing the value of our global brand."
• "This rebranding initiative will have a non-cash impact on the value of our tradename and trademark intangible assets which will be determined and recorded during our fourth quarter."
• "We believe that this additional oversight, coupled with the additional personnel now hired, will allow us to execute improved business process controls more quickly and ensure a greater level of monitoring whether controls are adequately designed and operating effectively."

Industry Context

The company operates in the government, defense, and commercial sectors, providing power solutions and communications systems. The decline in commercial sales, particularly in medical and oil & gas, suggests potential headwinds in these specific end-markets, possibly reflecting broader economic conditions or competitive pressures. The strong demand from a U.S.-based global prime in the Battery & Energy Products segment indicates continued strength in the defense sector, which often provides stability. The rebranding initiative aims to streamline market identity and strengthen competitive positioning, a common strategy in mature or consolidating industries.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• The company is subject to legal proceedings and claims that arise from time to time in the normal course of business, but management believes the final disposition of any such matters will not have a material adverse effect on the company's financial position, results of operations, or cash flows. No specific situations are currently known to have a material adverse impact.

Related Party Transactions

• NA

Stakeholder Impact

• **Shareholders**: Negative impact due to net loss for the quarter, significant decline in nine-month net income and EPS, and reduced gross margins. The material weakness in internal controls could also be a concern.
• **Employees**: Impacted by the closure of the Calgary facility by the end of 2025, leading to severance and other costs. New hires in the finance and accounting team indicate growth and strengthening in that department.
• **Customers**: Potential impact from quality issues on incoming components causing sales delays in the Battery & Energy Products segment and delays in purchase orders for Communications Systems. The rebranding aims to strengthen customer recognition and alignment.
• **Creditors**: The company remains in full compliance with its debt covenants, which is positive for creditors, but increased interest expense reflects higher borrowing costs.
• **Suppliers**: Quality issues on incoming components suggest potential challenges or increased scrutiny for certain suppliers.

Next Steps

• Continue efforts to tackle manufacturing inefficiencies, improve supply chain resiliency, and rationalize manufacturing operations.
• Advance new products into qualification and production.
• Capitalize on an expanding pipeline of large, multi-year programs.
• Advance vertical integration in the oil & gas segment.
• Maintain focus on operational efficiency initiatives.
• Complete the comprehensive rebranding initiative, which will result in a non-cash impact on tradename and trademark intangible assets in Q4.
• Continue remediation efforts for the material weakness in internal control over financial reporting, including further evaluation and testing.
• Monitor the utilization of domestic net operating loss carryforwards and tax credits.

Key Dates

Recommendation

Ultralife Corporation's Q3 2025 results show a concerning shift to a net loss and a substantial decline in nine-month net income and EPS, primarily driven by lower gross margins, increased operating expenses (including one-time costs), and higher interest expense from the Electrochem acquisition. Operational inefficiencies and a material weakness in internal controls are significant challenges. However, the company is actively addressing these issues through remediation efforts, a comprehensive rebranding initiative, and a focus on operational efficiency. The Electrochem acquisition, while impacting short-term profitability, is expected to drive future revenue growth and market penetration. Strong demand in the government/defense sector for Battery & Energy Products provides some stability. Given the mixed performance, with clear negatives but also proactive management responses and strategic growth avenues, a 'hold' recommendation is appropriate. Investors should monitor the effectiveness of remediation efforts, improvements in operational efficiency, and the realization of synergies from the Electrochem acquisition.

Keywords

Battery & Energy Products, Communications Systems, SEC 10-Q, Quarterly Report, Financial Results, Net Loss, Gross Margin, Operating Expenses, Electrochem Acquisition, Debt Financing, Internal Controls, Rebranding, Government Defense, Commercial Sales, Lithium Batteries, RF Amplifiers, Supply Chain, Capital Raise, ULBI